Stroke Treatment With Acute Reperfusion and Simvastatin
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether simvastatin treatment started within the
first 12 hours from stroke onset improves neurological and functional outcomes, evaluated at
seventh day/discharge or at the third month.
Also, to demonstrate that simvastatin is safe and not associated with higher rates of
hemorrhagic transformation in patients who receive thrombolysis.
Phase:
Phase 4
Details
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute